Forged Catalyst Group
Advisory and operating practice focused on converting available capital into deployed capability for deep-tech, healthtech, dual-use companies, regional innovation platforms, research institutions, and capital vehicles. Services combine capital-sequence design, commercialization program architecture, fund/vehicle structuring, federal opportunity alignment, and embedded senior operating leadership to improve evidence readiness, deployment capacity, and measurable conversion outcomes.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Operator-grade field notes and insights
Concise operational analysis and practitioner notes on capital sequencing, federal pursuit discipline, program design, and commercialization friction used as internal instruments and published sparingly.
Operator-grade field notes and insights
Concise operational analysis and practitioner notes on capital sequencing, federal pursuit discipline, program design, and commercialization friction used as internal instruments and published sparingly.
Services
Short diagnostic identifying where capital conversion is failing, constraint prioritization, and initial action recommendations.
Decision-grade capital and commercialization strategy covering opportunity alignment, funding architecture, institutional positioning, and execution priorities.
Comprehensive pursuit, partnership, and program or vehicle design for complex federal or multi-party initiatives.
Ongoing embedded senior operating leadership that owns the integrated capital strategy and runs pipelines, evidence, and board/funder readiness.
Self-serve instrument assessing seven dimensions of conversion to locate binding constraints and inform next steps.
Short diagnostic identifying where capital conversion is failing, constraint prioritization, and initial action recommendations.
Decision-grade capital and commercialization strategy covering opportunity alignment, funding architecture, institutional positioning, and execution priorities.
Comprehensive pursuit, partnership, and program or vehicle design for complex federal or multi-party initiatives.
Ongoing embedded senior operating leadership that owns the integrated capital strategy and runs pipelines, evidence, and board/funder readiness.
Self-serve instrument assessing seven dimensions of conversion to locate binding constraints and inform next steps.
Expertise Areas
- Capital strategy and sequencing
- Commercialization infrastructure for innovation platforms
- Investment vehicle design and fund formation
- Federal funding strategy and program positioning
Key Technologies
- Stage-gate frameworks
- Capital-sequencing methodology
- Diligence-readiness / data-room systems
- Pursuit architecture and go/no-go discipline
News & Updates
Operator note describing the structural difference between capital availability and capital conversion and where funders should measure outcomes.
Operator note reframing federal awards as tranches that must each remove a named risk and be sequenced into a capital stack.
Principal-led funding and contracts in excess of $250M reported as PI or Co-PI experience.
Program-level reporting that participating companies in the Capital Readiness program secured over $173M in private investment.
Program-level reporting that participating companies secured approximately $200M in non-dilutive federal funding (SBIR, ARPA-H, related).
Reported support in structuring and standing up completed fund closes totaling over $115M (program- and consortium-level outcomes).
Operator note describing the structural difference between capital availability and capital conversion and where funders should measure outcomes.
Operator note reframing federal awards as tranches that must each remove a named risk and be sequenced into a capital stack.
Principal-led funding and contracts in excess of $250M reported as PI or Co-PI experience.
Program-level reporting that participating companies in the Capital Readiness program secured over $173M in private investment.
Program-level reporting that participating companies secured approximately $200M in non-dilutive federal funding (SBIR, ARPA-H, related).
Reported support in structuring and standing up completed fund closes totaling over $115M (program- and consortium-level outcomes).